10x Genomics (TXG) Invested Capital (2018 - 2020)

10x Genomics has disclosed Invested Capital across 3 years of filings, most recently posting $739.1 million for Q4 2020.

• In Q4 2020, Invested Capital rose 64.31% year-over-year to $739.1 million; the TTM figure through Dec 2020 stood at $739.1 million (up 64.31% YoY), while the FY2020 annual figure was $739.1 million, up 64.31% from the prior year.
• Invested Capital came in at $739.1 million for Q4 2020 at 10x Genomics, down from $825.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $825.1 million in Q3 2020 to a low of -$190.3 million in Q4 2018.
• Average Invested Capital over 3 years is $439.3 million, with a median of $449.8 million recorded in 2019.
• Year-over-year, Invested Capital jumped 336.35% in 2019 and soared 64.31% in 2020.
• Over 3 years, Invested Capital stood at -$190.3 million in 2018, then surged by 336.35% to $449.8 million in 2019, then soared by 64.31% to $739.1 million in 2020.
• Per Business Quant data, the three most recent Invested Capital figures were $739.1 million in Q4 2020, $825.1 million in Q3 2020, and $391.3 million in Q2 2020.